Search research articles
Contact Us
Filters
Showing results (191-200 of 249) with videos related to
Page
of 25
Sort By:
Bone Marrow Transplantation
|
November 29, 2016
The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis
T Ruutu, A Gratwohl, D Niederwieser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 7, 2011
Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT)
E Jantunen, C Canals, M Attal, et al.
Bone Marrow Transplantation
|
November 8, 2016
Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT)
J R Passweg, H Baldomero, P Bader, et al.
Bone Marrow Transplantation
|
November 8, 2019
Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT
E Domingo-Domènech, A Boumendil, F Climent, et al.
Bone Marrow Transplantation
|
February 23, 2016
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
J R Passweg, H Baldomero, P Bader, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 24, 2016
Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
S Genadieva-Stavrik, A Boumendil, P Dreger, et al.
Leukemia
|
May 6, 2016
Post-transplant cyclophosphamide-based haplo-identical transplantation as alternative to matched sibling or unrelated donor transplantation for non-Hodgkin lymphoma: a registry study by the European society for blood and marrow transplantation
S Dietrich, H Finel, C Martinez, et al.
Blood Cancer Journal
|
August 9, 2014
Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression
Y Oki, D Buglio, J Zhang, et al.
Bone Marrow Transplantation
|
January 31, 2006
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe
P Ljungman, A Urbano-Ispizua, M Cavazzana-Calvo, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
July 17, 2019
Corrigendum to "Antidepressive effects of a chemically characterized maqui berry extract (Aristotelia chilensis (molina) stuntz) in a mouse model of Post-stroke depression" [Food Chem. Toxicol. 129 (2019) 434-443]
A Di Lorenzo, A P Sobolev, S F Nabavi, et al.
Page
of 25
Search research articles
Search
Showing results (191-200 of 249) with videos related to
Sort By:
Page
of 25
Bone Marrow Transplantation
|
November 29, 2016
The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis
T Ruutu, A Gratwohl, D Niederwieser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 7, 2011
Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT)
E Jantunen, C Canals, M Attal, et al.
Bone Marrow Transplantation
|
November 8, 2016
Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT)
J R Passweg, H Baldomero, P Bader, et al.
Bone Marrow Transplantation
|
November 8, 2019
Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT
E Domingo-Domènech, A Boumendil, F Climent, et al.
Bone Marrow Transplantation
|
February 23, 2016
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
J R Passweg, H Baldomero, P Bader, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 24, 2016
Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
S Genadieva-Stavrik, A Boumendil, P Dreger, et al.
Leukemia
|
May 6, 2016
Post-transplant cyclophosphamide-based haplo-identical transplantation as alternative to matched sibling or unrelated donor transplantation for non-Hodgkin lymphoma: a registry study by the European society for blood and marrow transplantation
S Dietrich, H Finel, C Martinez, et al.
Blood Cancer Journal
|
August 9, 2014
Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression
Y Oki, D Buglio, J Zhang, et al.
Bone Marrow Transplantation
|
January 31, 2006
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe
P Ljungman, A Urbano-Ispizua, M Cavazzana-Calvo, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
July 17, 2019
Corrigendum to "Antidepressive effects of a chemically characterized maqui berry extract (Aristotelia chilensis (molina) stuntz) in a mouse model of Post-stroke depression" [Food Chem. Toxicol. 129 (2019) 434-443]
A Di Lorenzo, A P Sobolev, S F Nabavi, et al.
Page
of 25